Drug Target Review

OCTOBER 25, 2024

Biomarkers are an essential advancement that will help determine risk for developing Alzheimer’s disease, diagnose the disease before symptoms have progressed significantly, predict how quickly patients may experience cognitive decline and evaluate how well new therapies are working. Progress in molecular biology and translational science.

Disease 59

Disease Clinical Trials Therapies Science 59

The Pharma Data

JANUARY 4, 2021

. chPD1 will be used in the Company’s proprietary chimeric antigen receptor therapy (CAR-T) platform using gamma-delta T-cells (GD-T). Barber’s work will give Kiromic a significant acceleration in the clinical development of its therapy platform and an even more significant advantage over its competitors.

Molecular Biology 40

Molecular Biology Therapies Immune Response Science 40

Broad Institute

JUNE 25, 2025

The scientists suggest that new therapies that target these genes could directly address fibrosis and potentially be more effective for this complication than existing drugs, which are primarily focused on reducing inflammation. It could also help doctors better treat patients with existing drugs.

Disease 111

Disease Medical Schools RNA Molecular Biology 111

Codon

FEBRUARY 13, 2024

Tom Ireland writes about the companies and technologies that are reimagining phage therapy. Soon after its publication, scientists, journalists, and investors were revisiting ‘phage therapy’ as a promising alternative to our failing antibiotics. Read it on our website here. Illustration by David S. Fast forward to 2023.

Therapies 136

Therapies Virus DNA Clinical Trials 136

Drug Target Review

MARCH 15, 2024

He has a post-doctorate in virology, viral pathogenesis, viral vector development, and vaccines evaluation from Harvard Medical School, and a PhD in virology/molecular biology. Cell Gene Therapy Insights 2017; 3(2), 131-158, 10.18609/cgti.2017.014. Biotechnol Prog. 2017 Nov;33(6):1468-1475. doi: 10.1002/btpr.2548.

Engineering 105

Engineering Molecular Biology Protein Expression Medical Schools 105

Codon

JULY 27, 2023

But what happens if you restore these cone cells, using gene therapy? in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” From McKyton et al.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

JULY 27, 2023

But what happens if you restore these cone cells, using gene therapy? in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” From McKyton et al.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

DECEMBER 17, 2023

Molecular biology, as the field came to be called 3 , pushed biology from an object of study, driven forward by gentleman scientists and precocious country clergymen, into a tool with which to solve urgent problems. At least six CAR-T cancer therapies have now garnered F.D.A. Steelman: Biotechnology is not a panacea.

Engineering 52

Engineering Molecular Biology Doctors DNA 52

Broad Institute

JANUARY 30, 2024

He majored in biological chemistry at the University of Chicago and during his junior year, he had a fortuitous meeting with his academic advisor about finding a student research position that would let him dive more deeply into the molecular details of biological systems. A combined MD/PhD program offered both opportunities.

Hospitals 137

Hospitals Virus Medical Schools Science 137

Drug Target Review

DECEMBER 9, 2024

Leading a company that develops novel therapies for complex diseases, I have navigated the challenge of securing funding, which is often more difficult for women-led companies. Looking ahead, I see a future where therapies not only treat diseases but also prevent them by restoring the body’s natural ability to regenerate and heal.

Therapies 52

Therapies Disease Pharmaceuticals Molecular Biology 52